Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Goldberg

Showing results (941-950 of 1,004) with videos related to

Pageof 101
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2017
The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ TransplantationJ Levitsky, R N Formica, R D Bloom, et al.
Molecular Genetics and Metabolism|April 15, 2017
Brain MRS glutamine as a biomarker to guide therapy of hyperammonemic comaAnne H O'Donnell-Luria, Alexander P Lin, Sai K Merugumala, et al.
Journal of Neurology|August 12, 2025
Multi-modal proton and sodium MRI for outcome prediction in mild traumatic brain injuryAnna M Chen, Teresa Gerhalter, Zhongyang Ma, et al.
Journal for Immunotherapy of Cancer|November 30, 2022
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanomaNikhil I Khushalani, Melinda Vassallo, Judith D Goldberg, et al.
Cancer|December 22, 2022
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemiaTalha Badar, Mark R Litzow, Rory M Shallis, et al.
Journal of Medicinal Chemistry|April 16, 2025
Identification of JNJ-61803534, a RORγt Inverse Agonist for the Treatment of PsoriasisOlaf Kinzel, Steven D Goldberg, Maxwell D Cummings, et al.
Blood Advances|December 20, 2018
Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasmsRaajit K Rampal, John O Mascarenhas, Heidi E Kosiorek, et al.
Blood Advances|March 9, 2021
Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AMLMaximilian Stahl, Kamal Menghrajani, Andriy Derkach, et al.
Leukemia|February 20, 2024
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AMLShai Shimony, Jan Philipp Bewersdorf, Rory M Shallis, et al.
The British Journal of Dermatology|August 25, 2015
Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelinesJ E Mellerio, S J Robertson, C Bernardis, et al.
Pageof 101

Showing results (941-950 of 1,004) with videos related to

Sort By:
Pageof 101
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2017
The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ TransplantationJ Levitsky, R N Formica, R D Bloom, et al.
Molecular Genetics and Metabolism|April 15, 2017
Brain MRS glutamine as a biomarker to guide therapy of hyperammonemic comaAnne H O'Donnell-Luria, Alexander P Lin, Sai K Merugumala, et al.
Journal of Neurology|August 12, 2025
Multi-modal proton and sodium MRI for outcome prediction in mild traumatic brain injuryAnna M Chen, Teresa Gerhalter, Zhongyang Ma, et al.
Journal for Immunotherapy of Cancer|November 30, 2022
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanomaNikhil I Khushalani, Melinda Vassallo, Judith D Goldberg, et al.
Cancer|December 22, 2022
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemiaTalha Badar, Mark R Litzow, Rory M Shallis, et al.
Journal of Medicinal Chemistry|April 16, 2025
Identification of JNJ-61803534, a RORγt Inverse Agonist for the Treatment of PsoriasisOlaf Kinzel, Steven D Goldberg, Maxwell D Cummings, et al.
Blood Advances|December 20, 2018
Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasmsRaajit K Rampal, John O Mascarenhas, Heidi E Kosiorek, et al.
Blood Advances|March 9, 2021
Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AMLMaximilian Stahl, Kamal Menghrajani, Andriy Derkach, et al.
Leukemia|February 20, 2024
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AMLShai Shimony, Jan Philipp Bewersdorf, Rory M Shallis, et al.
The British Journal of Dermatology|August 25, 2015
Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelinesJ E Mellerio, S J Robertson, C Bernardis, et al.
Pageof 101